IP Verse

Use Of Akkermansia For Treating Metabolic Disorders - EP2919796

The patent EP2919796 was granted to Universit Catholique DE Louvain on Apr 28, 2021. The application was originally filed on Nov 15, 2013 under application number EP13792006A. The patent is currently recorded with a legal status of "Revoked".

EP2919796

UNIVERSIT CATHOLIQUE DE LOUVAIN
Application Number
EP13792006A
Filing Date
Nov 15, 2013
Status
Revoked
Jun 7, 2024
Grant Date
Apr 28, 2021
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

STRAWMANJan 28, 2022AVIDITYADMISSIBLE

Patent Citations (8) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONEP2030623
DESCRIPTIONWO2008076696
DESCRIPTIONWO2011107481
INTERNATIONAL-SEARCH-REPORTEP2030623
INTERNATIONAL-SEARCH-REPORTWO2008076696
INTERNATIONAL-SEARCH-REPORTWO2013130773
OPPOSITIONUS8192733
OPPOSITIONWO2008076696

Non-Patent Literature (NPL) Citations (32) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- ALHOUAYEK ET AL., FASEB J, (2011), vol. 25, pages 2711 - 2721-
DESCRIPTION- BELZER ET AL., ISME J, (2012), vol. 6, pages 1449 - 1458-
DESCRIPTION- BEN-SHABAT ET AL., EUR.J.PHARMACOL., (1998), vol. 353, pages 23 - 31-
DESCRIPTION- DELZENNE; CANI, ANNU. REV. NUTR., (2011), vol. 31, pages 15 - 31-
DESCRIPTION- DERRIEN ET AL., APPLIED ENVIRONMENTAL MICROBIOLOGY, (2008), vol. 74, pages 1646 - 1648-
DESCRIPTION- DERRIEN ET AL., FRONT MICROBIOL, (2011), vol. 2, page 166-
DESCRIPTION- DERRIEN ET AL., INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY, (2004), vol. 54, pages 1469 - 1476-
DESCRIPTION- DERRIEN ET AL., INT J SYST EVOL MICROBIOL, (2004), vol. 54, pages 1469 - 1476-
DESCRIPTION- EVERARD ET AL., DIABETES, (201111), vol. 60, no. 11, pages 2775 - 86-
DESCRIPTION- EVERARD ET AL., DIABETES, (2011), vol. 60, pages 2775 - 2786-
DESCRIPTION- GEURTS ET AL., FRONT MICROBIOL., (2011), vol. 2, page 149-
DESCRIPTION- HANSEN ET AL., DIABETOLOGIA, (201208), vol. 55, no. 8, pages 2285 - 94-
DESCRIPTION- HANSEN ET AL., J CLIN ENDOCRINOL METAB, vol. 96, pages E1409 - 1417-
DESCRIPTION- JOHANSSON ET AL., PROC NATL ACAD SCI USA, vol. 108, no. 1, pages 4659 - 4665-
DESCRIPTION- MUCCIOLI ET AL., MOL SYST BIOL, (2010), vol. 6, page 392-
DESCRIPTION- VAISHNAVA, S. ET AL., SCIENCE, (2011), vol. 334, pages 255 - 258-
DESCRIPTION- VAN PASSEL ET AL., PLOS ONE, (2011), vol. 6, page E16876-
DESCRIPTION- ZOETENDAL, RAJILIC-STOJANOVIC; DE VOS, GUT, (2008), vol. 57, pages 1605 - 1615-
INTERNATIONAL-SEARCH-REPORT- HANSEN C H F ET AL, "Early life treatment with vancomycin propagatesand reduces diabetes incidence in the NOD mouse", DIABETOLOGIA ; CLINICAL AND EXPERIMENTAL DIABETES AND METABOLISM, SPRINGER, BERLIN, DE, (20120510), vol. 55, no. 8, doi:10.1007/S00125-012-2564-7, ISSN 1432-0428, pages 2285 - 2294, XP035081573 [A] 1-17 * abstract *
INTERNATIONAL-SEARCH-REPORT- LE ROY T ET AL, "GUT MICROBIOTA TRANSPLANTATION DEMONSTRATES ITS CAUSAL ROLE IN THE DEVELOPMENT OF TYPE 2 DIABETES AND FATTY LIVER", JOURNAL OF HEPATOLOGY; 47TH ANNUAL MEETING OF THE EUROPEAN-ASSOCIATION-FOR-THE-STUDY-OF-THE-LIVER (EASL), MUNKSGAARD INTERNATIONAL PUBLISHERS, COPENHAGEN, DK; BARCELONA, SPAIN, vol. 56, no. Suppl. 2, doi:10.1016/S0168-8278(12)60065-8, ISSN 0168-8278, (201204), page S23, (20120423), XP008159945 [X] 1-7,14,15,17 * abstract * [I] 1-17
INTERNATIONAL-SEARCH-REPORT- A. EVERARD ET AL, "Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, (20130528), vol. 110, no. 22, doi:10.1073/pnas.1219451110, ISSN 0027-8424, pages 9066 - 9071, XP055074467 [T] * abstract *
INTERNATIONAL-SEARCH-REPORT- M. DERRIEN ET AL, "Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium", INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY, (200409), vol. 54, no. 5, doi:10.1099/ijs.0.02873-0, ISSN 1466-5026, pages 1469 - 1476, XP055074486 [X] 4-7,14,15,17 * page 54, left column, paragraph 3-right column, paragraph 5;; figure 3; table 1 *
INTERNATIONAL-SEARCH-REPORT- MARK W. J. VAN PASSEL ET AL, "The Genome of Akkermansia muciniphila, a Dedicated Intestinal Mucin Degrader, and Its Use in Exploring Intestinal Metagenomes", PLOS ONE, (20110303), vol. 6, no. 3, doi:10.1371/journal.pone.0016876, page e16876, XP055074483 [X] 4-7,14,15,17 * abstract page e16876, right column paragraph 3 *
INTERNATIONAL-SEARCH-REPORT- MURIEL DERRIEN ET AL, "Modulation of Mucosal Immune Response, Tolerance, and Proliferation in Mice Colonized by the Mucin-Degrader Akkermansia muciniphila", FRONTIERS IN MICROBIOLOGY, (201101), vol. 2, doi:10.3389/fmicb.2011.00166, XP055074491 [X] 4-7,14,15,17 * abstract page 2, right column, paragraph 4-page 3, left column, paragraph 2 *
OPPOSITION- Everard, A, "Akkermansia muciniphila link gut barrier function with inflammation and metabolic disorders associated with obesity", Keystone Symposia: The Microbiome, (20120301), Keystone Symposia: The Microbiome, (20210915), XP055841240-
OPPOSITION- P. CANI, "Gut Microbiota, Obesity And Type 2 Diabetes: Insights Into The Prebiotics", Terzo Congresso Nazionale Della Societa ' Italian a di Nutraceutica - Sinut, (20120920), page 17, XP055891082-
OPPOSITION- C. H. F. Hansen; L. Krych; D. S. Nielsen; F. K. Vogensen; L. H. Hansen; S. J. SÃ ̧rensen; K. Buschard; A. K. Hansen, "Early life treatment with vancomycin propagatesand reduces diabetes incidence in the NOD mouse", Diabetologia, Springer, Berlin, DE, Berlin, DE , (20120510), vol. 55, no. 8, doi:10.1007/s00125-012-2564-7, ISSN 1432-0428, pages 2285 - 2294, XP035081573
OPPOSITION- P.J. TURNBAUGH et al., "An obesity-associated gut microbiome with increased capacity for energy harvest", Nature, (20061221), vol. 444, no. 7122, doi:10.1038/nature05414, pages 1027 - 31, XP002510854
OPPOSITION- V. TREMAROLI et al., "Functional interactions between the gut microbiota and host metabolism", Nature, (20120900), vol. 489, doi:10.1038/nature11552, page 242, XP055061277
OPPOSITION- DERRIEN et al., "Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium", Int. J. Syst. Evol. Microbiol., (20040000), vol. 54, doi:10.1099/ijs.0.02873-0, pages 1469 - 1476, XP055074486
OPPOSITION- Muriel Derrien, Van Baarlen Peter, Hooiveld Guido, Norin Elisabeth, Müller Michael, De Vos Willem M., "Modulation of Mucosal Immune Response, Tolerance, and Proliferation in Mice Colonized by the Mucin-Degrader Akkermansia muciniphila", Frontiers in Microbiology, (20110101), vol. 2, doi:10.3389/fmicb.2011.00166, XP055074491
OPPOSITION- Patrice D. Cani, Melania Osto, Lucie Geurts, Amandine Everard, "Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity", Gut Microbes, Landes Bioscience, United States, United States , (20120714), vol. 3, no. 4, doi:10.4161/gmic.19625, ISSN 1949-0976, pages 279 - 288, XP055247000

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents